Search Results | Blood | American Society of Hematology

1-20 of 63

2 3 4

Sort by

Sort Order Select

Journal Articles

Histopathologic Characterization of Vexas Syndrome

Mohammad I. Barouqa, Aishwarya Ravindran, Dong Chen, Jennifer L Oliveira, Horatiu Olteanu, Matthew T Howard, Gang Zheng, Mrinal M. Patnaik, Kebede H. Begna, Allison M. Bock, Ronald Go, Matthew Koster, Taxiarchis Kourelis, Abhishek A. Mangaonkar, Jay Ryu, Matthew Samec, Julio C. Sartori Valinotti, Kenneth Warrington, Kaaren K. Reichard

Blood (2021) 138 (Supplement 1): 4656.

DOI: https://doi.org/10.1182/blood-2021-152739

Published: 2021

Journal Articles

Anthracycline Choices for Induction Chemotherapy Among 797 Consecutive Adult Patients with Acute Myeloid Leukemia: Daunorubicin-60 Vs Idarubicin-12 Vs Daunorubicin-90

Kebede H. Begna, Naseema Gangat, Mithun V. Shah, Hassan B. Alkhateeb, Mrinal M. Patnaik, Aref Al-Kali, Michelle A. Elliot, William J Hogan, Mark R. Litzow, C. Christopher Hook, Abhishek A. Mangaonkar, David S Viswanatha, Dong Chen, Animesh D. Pardanani, Rhett P. Ketterling, Ayalew Tefferi

Blood (2021) 138 (Supplement 1): 1267.

DOI: https://doi.org/10.1182/blood-2021-147485

Published: 2021

Journal Articles

Disease-Modifying Potential of BET Inhibitor Pelabresib (CPI-0610) As Demonstrated By Improvements in Bone Marrow Function and Clinical Activity in Patients with Myelofibrosis - Preliminary Data

Blood (2021) 138 (Supplement 1): 2568.

DOI: https://doi.org/10.1182/blood-2021-152267

Published: 2021

Journal Articles

Acute Myeloid Leukemia in the Context of Previous History of Cancer with or without Exposure to Chemotherapy or Radiotherapy

Kebede H. Begna, Mithun V. Shah, Naseema Gangat, Hassan B. Alkhateeb, Mrinal M. Patnaik, Aref Al-Kali, Michelle A. Elliot, William J Hogan, Mark R. Litzow, C. Christopher Hook, Abhishek A. Mangaonkar, Rong He, Dong Chen, Animesh Pardanani, Rhett P. Ketterling, Ayalew Tefferi

Blood (2021) 138 (Supplement 1): 3368.

DOI: https://doi.org/10.1182/blood-2021-145745

Published: 2021

Journal Articles

A Thrombospondin-1 Release Assay (TRA) Coupled to PF4-Treated Cryopreserved Platelets for the Detection of Pathogenic HIT and VITT Antibodies

Adam Kanack, Curtis Jones, Bandana Singh, Gemlyn George, Mouhamed Yazan Abou-Ismail, David L. Green, Alison Grazioli, Rachel Leger, Nahla M. Heikal, Dong Chen, Rajiv K. Pruthi, Anand Padmanabhan

Blood (2021) 138 (Supplement 1): 2130.

DOI: https://doi.org/10.1182/blood-2021-152953

Published: 2021

Journal Articles

Therapy-Related Cytopenia of Undetermined Significance (t-CCUS) As a Precursor to Therapy-Related Myeloid Neoplasms (t-MN)

Mithun V. Shah, Abhishek A. Mangaonkar, Kebede H. Begna, Hassan B. Alkhateeb, Patricia Greipp, Dong Chen, David S. Viswanatha, Rong He, Michelle A Elliott, William J Hogan, Mark R. Litzow, Kristen McCullough, Ayalew Tefferi, Naseema Gangat, Mrinal M. Patnaik, Aref Al-Kali

Blood (2021) 138 (Supplement 1): 1096.

DOI: https://doi.org/10.1182/blood-2021-145696

Published: 2021

Journal Articles

No Diagnostic Utility of Zero Heparin Control Buffer in Serotonin Release Assay: Findings from a Validation Study

Abdulrahman Saadalla, Rachel Leger, Aneel A. Ashrani, Rajiv K. Pruthi, Dong Chen, Anand Padmanabhan, Nahla Heikal

Blood (2021) 138 (Supplement 1): 3227.

DOI: https://doi.org/10.1182/blood-2021-154209

Published: 2021

Journal Articles

Diagnostic Utility of High Dose Heparin Confirmation Step in Heparin Induced Thrombocytopenia ELISA Assay

Abdulrahman Saadalla, Rachel Leger, Aneel A. Ashrani, Rajiv K. Pruthi, Dong Chen, Anand Padmanabhan, Nahla Heikal

Blood (2021) 138 (Supplement 1): 3228.

DOI: https://doi.org/10.1182/blood-2021-154504

Published: 2021

Journal Articles

A prospective, blinded study of a PF4-dependent assay for HIT diagnosis

Bethany Samuelson Bannow, Deepti M. Warad, Curtis G. Jones, Shannon M. Pechauer, Brian R. Curtis, Daniel W. Bougie, Ruchika Sharma, Diane E. Grill, Mary W. Redman, Parisa R. Khalighi, Rachel R. Leger, Rajiv K. Pruthi, Dong Chen, Daniel E. Sabath, Richard H. Aster, David A. Garcia, Anand Padmanabhan

Blood (2021) 137 (8): 1082–1089.

DOI: https://doi.org/10.1182/blood.2020008195

Published: 2021

Includes: Supplemental data

Journal Articles

Combinatorial treatment with menin and FLT3 inhibitors induces complete remission in AML models with activating FLT3 mutations

Hongzhi Miao, EunGi Kim, Dong Chen, Trupta Purohit, Katarzyna Kempinska, James Ropa, Szymon Klossowski, Winifred Trotman, Gwenn Danet-Desnoyers, Tomasz Cierpicki, Jolanta Grembecka

Blood (2020) 136 (25): 2958–2963.

DOI: https://doi.org/10.1182/blood.2020006575

Published: 2020

Includes: Supplemental data

Journal Articles

Spectrum of Hematological Malignancies in 130 Patients with Germline Predisposition Syndromes - Mayo Clinic Germline Predisposition Study

Blood (2020) 136 (Supplement 1): 34–35.

DOI: https://doi.org/10.1182/blood-2020-139050

Published: 2020

Journal Articles

Detection of Monoclonal Immunoglobulin By Mass Spectrometry in Patients Evaluated for Thrombotic Microangiopathy (TMA)

Paul J. Hampel, MD, David L. Murray, MDPhD, Rajiv K. Pruthi, M.B.B.S, Aishwarya Ravindran, MBBS, Dong Chen, MD, PhD, Ronald S. Go, MD

Blood (2020) 136 (Supplement 1): 17.

DOI: https://doi.org/10.1182/blood-2020-137546

Published: 2020

Journal Articles

Thrombophilia Testing Practices: The Mayo Clinic Experience

Caleb J Scheckel, DO, Rajiv K. Pruthi, M.B.B.S, Ariela L. Marshall, MD, Aneel A. Ashrani, MD MS, Dong Chen, MD, PhD, Nahla M. Heikal, MD

Blood (2020) 136 (Supplement 1): 39–40.

DOI: https://doi.org/10.1182/blood-2020-141633

Published: 2020

Journal Articles

The Combinatorial Activity of Eftozanermin (ABBV-621), a Novel and Potent TRAIL Receptor Agonist Fusion Protein, in Pre-Clinical Models of Hematologic Malignancies

Morey L Smith, MS, Sha Jin, MS, Dong Chen, MS, Haichao Zhang, PhD, Jason Huska, PhD, Deborah Widomski, Vicky Bontcheva, Greg Buchanan, PhD, Susan Morgan-Lappe, PhD, Darren C. Phillips, PhD, Stephen K Tahir, PhD

Blood (2020) 136 (Supplement 1): 41.

DOI: https://doi.org/10.1182/blood-2020-136155

Published: 2020

Journal Articles

Determination of Relapse Risk By Complement Gene Variants after Eculizumab Discontinuation in Complement-Mediated Thrombotic Microangiopathy: A Retrospective Review

Aldo A. Acosta-Medina, MD, Ann M. Moyer, MDPhD, Ronald S. Go, MD, Maria Alice V. Willrich, PhD, Hassan B. Alkhateeb, MD, Christianne Bourlon De Los Rios, MDMSc, Dong Chen, MD, PhD, Fernando C. Fervenza, MDPhD, Nahla M. Heikal, MD, Nelson Leung, MD, Ariela L. Marshall, MD, Cheryl L. Tran, MD, Jeffrey L. Winters, MD, Meera Sridharan, MD PhD

Blood (2020) 136 (Supplement 1): 25–26.

DOI: https://doi.org/10.1182/blood-2020-136617

Published: 2020

Journal Articles

Evaluation of Soluble Fibrin Monomer Complex in Patients with Sars-Cov-2 COVID-19 Infection

Meera Sridharan, MD PhD, Aneel A. Ashrani, MD MS, Dong Chen, MD, PhD, Nahla M. Heikal, MD, Ariela L. Marshall, MD, Rajiv K. Pruthi, M.B.B.S

Blood (2020) 136 (Supplement 1): 27–28.

DOI: https://doi.org/10.1182/blood-2020-136717

Published: 2020

Journal Articles

Acute Myeloid Leukemia with High Risk Features: Routine Central Nervous System Evaluation May be Beneficial

Meera Yogarajah, MD, William J Hogan, MB, BCh, Naseema Gangat, MBBS, Dong Chen, MD PhD, Rong He, MD, Hassan B. Alkhateeb, MD, Mithun Vinod Shah, MD PhD, Mrinal M Patnaik, MDMBBS, Michelle A Elliott, MD, Mark Litzow, MD, Aref Al-Kali, MD, Animesh Pardanani, MBBS, PhD, Ayalew Tefferi, MD, Kebede H. Begna, MD

Blood (2019) 134 (Supplement_1): 3863.

DOI: https://doi.org/10.1182/blood-2019-125361

Published: 2019

Journal Articles

Characteristics and Outcomes of Therapy Related Myeloid Neoplasms in Patients with Multiple Myeloma Following Autologous Stem Cell Transplantation

Kalyan Nadiminti, M Hasib Sidiqi, MBBS, Kapil Meleveedu, MDMBBS, Hassan B. Alkhateeb, MD, Aref Al-Kali, MD, William J Hogan, MB, BCh, Mark Litzow, MD, Shaji K. Kumar, MD, Mrinal M Patnaik, MDMBBS, Morie A. Gertz, MD, Dong Chen, MD PhD, Mithun Vinod Shah, MD PhD

Blood (2019) 134 (Supplement_1): 4560.

DOI: https://doi.org/10.1182/blood-2019-123065

Published: 2019

Journal Articles

Spectrum of Abnormalities and Clonal Transformation in Germline RUNX1 Familial Platelet Disorder and a Comparative Analysis with Somatic RUNX1 Mutations in Myeloid Neoplasms

Emma Difilippo, BS, Giacomo Coltro, MD, Ryan M. Carr, MD PhD, Abhishek A Mangaonkar, MBBS, Moritz Binder, MDMPH, Shakila P Khan, MD, Vilmarie Rodriguez, MD, Naseema Gangat, MBBS, Alexandra Wolanskyj, MD, Rajiv K. Pruthi, MBBS, Dong Chen, MD PhD, Rong He, MD, David S Viswanatha, MD, Terra Lasho, PhD, Christy Finke, BS, Ayalew Tefferi, MD, Animesh Pardanani, MBBS, PhD, Mark Litzow, MD, Mrinal M Patnaik, MDMBBS

Blood (2019) 134 (Supplement_1): 3003.

DOI: https://doi.org/10.1182/blood-2019-124830

Published: 2019

Journal Articles

1,123 Consecutive Adults with Non-APL Acute Myeloid Leukemia: The Mayo Clinic Experience

Kebede H. Begna, MD, Walid Ali, MD, Naseema Gangat, MBBS, Michelle A. Elliott, MD, Aref Al-Kali, MD, Mark R. Litzow, MD, C. Christopher Hook, MD, Alexandra Wolanskyj, MD, William J. Hogan, MBBCh, Mrinal M. Patnaik, MD MBBS, Animesh Pardanani, MBBS, PhD, Darci Zblewski, APRN, C-NP, Dong Chen, MD PhD, Rong He, MD, David S Viswanatha, MD, Curtis A. Hanson, MD, Rhett P. Ketterling, Ayalew Tefferi, MD

Blood (2018) 132 (Supplement 1): 2689.

DOI: https://doi.org/10.1182/blood-2018-99-110811

Published: 2018

2 3 4

NARROW

Histopathologic Characterization of Vexas Syndrome

Anthracycline Choices for Induction Chemotherapy Among 797 Consecutive Adult Patients with Acute Myeloid Leukemia: Daunorubicin-60 Vs Idarubicin-12 Vs Daunorubicin-90

Disease-Modifying Potential of BET Inhibitor Pelabresib (CPI-0610) As Demonstrated By Improvements in Bone Marrow Function and Clinical Activity in Patients with Myelofibrosis - Preliminary Data

Acute Myeloid Leukemia in the Context of Previous History of Cancer with or without Exposure to Chemotherapy or Radiotherapy

A Thrombospondin-1 Release Assay (TRA) Coupled to PF4-Treated Cryopreserved Platelets for the Detection of Pathogenic HIT and VITT Antibodies

Therapy-Related Cytopenia of Undetermined Significance (t-CCUS) As a Precursor to Therapy-Related Myeloid Neoplasms (t-MN)

No Diagnostic Utility of Zero Heparin Control Buffer in Serotonin Release Assay: Findings from a Validation Study

Diagnostic Utility of High Dose Heparin Confirmation Step in Heparin Induced Thrombocytopenia ELISA Assay

A prospective, blinded study of a PF4-dependent assay for HIT diagnosis

Combinatorial treatment with menin and FLT3 inhibitors induces complete remission in AML models with activating FLT3 mutations

Spectrum of Hematological Malignancies in 130 Patients with Germline Predisposition Syndromes - Mayo Clinic Germline Predisposition Study

Detection of Monoclonal Immunoglobulin By Mass Spectrometry in Patients Evaluated for Thrombotic Microangiopathy (TMA)

Thrombophilia Testing Practices: The Mayo Clinic Experience

The Combinatorial Activity of Eftozanermin (ABBV-621), a Novel and Potent TRAIL Receptor Agonist Fusion Protein, in Pre-Clinical Models of Hematologic Malignancies

Determination of Relapse Risk By Complement Gene Variants after Eculizumab Discontinuation in Complement-Mediated Thrombotic Microangiopathy: A Retrospective Review

Evaluation of Soluble Fibrin Monomer Complex in Patients with Sars-Cov-2 COVID-19 Infection

Acute Myeloid Leukemia with High Risk Features: Routine Central Nervous System Evaluation May be Beneficial

Characteristics and Outcomes of Therapy Related Myeloid Neoplasms in Patients with Multiple Myeloma Following Autologous Stem Cell Transplantation

Spectrum of Abnormalities and Clonal Transformation in Germline RUNX1 Familial Platelet Disorder and a Comparative Analysis with Somatic RUNX1 Mutations in Myeloid Neoplasms

1,123 Consecutive Adults with Non-APL Acute Myeloid Leukemia: The Mayo Clinic Experience

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only